The Patent Finder

Cloudbreak Therapeutics, LLC

Also on record
Records under this name other than the patents Cloudbreak Therapeutics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Showing 1 to 9 of 9 · Back to Cloudbreak Therapeutics, LLC

PatentTitleStatus Expires Confidence
US 10,335,408Compositions and Methods of Using Nintedanib for Improving Glaucoma Surgery Success
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,688,092Compositions and Methods of Using Nintedanib for Improving Glaucoma Surgery Success
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,911,379Compositions and Methods of Using Nintedanib for Treating Ocular Diseases with Abnormal Neovascularization
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,491,183Compositions and Methods of Using Nintedanib for Treating Ocular Diseases with Abnormal Neovascularization
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,179,388Topical composition for treating rosacea and a method for treating rosacea with the same
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,744,153Compositions and methods for treating meibomian gland dysfunction
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,166,977Compositions for treating meibomian gland dysfunction
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,007,214Compositions and methods for treating eye diseases
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,156,873Composition for treating ocular hyperemia and a method for treating ocular hyperemia with the same
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited